Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver Metastases
- 1 December 2010
- journal article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 9 (5), 311-314
- https://doi.org/10.3816/ccc.2010.n.045
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)Journal of Clinical Oncology, 2006
- Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the Fédération Nationale des Centres de Lutte Contre le CancerJournal of Clinical Oncology, 2005
- Hepatic Arterial Infusion after Liver ResectionThe New England Journal of Medicine, 2005
- Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overviewCancer Treatment Reviews, 2004
- Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.2004
- Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.2003
- Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancerAnnals of Oncology, 2001
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerThe New England Journal of Medicine, 1999
- Pharmacologic rationale for regional drug delivery.Journal of Clinical Oncology, 1984